NCT07053514

Brief Summary

The goal of this study is to develop and implement a same-day ART (SD-ART) protocol for key affected populations with HIV in Peru. The development of the protocol will be guided by asynchronous online focus groups with HIV experts to define eligibility criteria and essential components of the protocol, as well as nominal group technique focus groups and in-depth interviews to identify barriers and facilitators to SD-ART implementation. Finally, investigators will pilot the SD-ART protocol with patients and clinicians using a prospective, longitudinal design integrated into routine HIV care.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
139

participants targeted

Target at P25-P50 for not_applicable hiv

Timeline
12mo left

Started Jul 2027

Shorter than P25 for not_applicable hiv

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 26, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 8, 2025

Completed
2 years until next milestone

Study Start

First participant enrolled

July 1, 2027

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2028

Last Updated

July 8, 2025

Status Verified

June 1, 2025

Enrollment Period

1 year

First QC Date

June 26, 2025

Last Update Submit

June 26, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Reductions in patient HIV and multi-dimensional stigma

    Assessed using a modified 10-item version of the Berger HIV stigma scale, which has been previously translated into Spanish and validated in Peru. Total score range from 40 to 160. Higher scores denote higher levels of HIV stigma.

    baseline, month 1, month 3, month 6, month 9, and month 12

  • Provider stigma toward patients

    Measured through feeling thermometers (on a scale from 0-100) of various identity groups (people with HIV, sexual minorities, people who use drugs).

    baseline, month 1, month 3, month 6, month 9, and month 12

  • Everyday Discrimination Scale

    This is a 5-item scale that is rated on a 6-point scale (range from 0 to 30), with higher scores denoting higher levels of multi-dimensional stigma and experiences with discrimination

    baseline, month 1, month 3, month 6, month 9, and month 12

Study Arms (2)

People With HIV (PWH)

EXPERIMENTAL

SD-ART protocol for PWH prescribed by their HIV clinicians

Behavioral: SD-ART

Clinicians prescribing ART

NO INTERVENTION

Interventions

SD-ARTBEHAVIORAL

SD-ART protocol for PWH with both patients and their HIV clinicians

People With HIV (PWH)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aim 1:
  • HIV experts will be selected from National Societies of HIV experts according to the following criteria: 1) 18 years old or older; 2) Be an HIV expert, including those from NGOs providing HIV care, and international specialists; 3) Provide informed consent.
  • Aim 2:
  • NGT Focus Groups (FG)
  • Staff members
  • years old or older.
  • Be a clinical staff member at Hospital Dos de Mayo or Patrucco Primary Health Center.
  • Provide informed consent.
  • PWH receiving HIV care
  • years old or older.
  • Identify as member of a KAP.
  • Receive HIV care at Hospital Dos de Mayo or Patrucco Primary Health.
  • Provide informed consent.
  • PWH who dropped out of HIV care
  • years old or older.
  • +18 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centro de Salud Raul Patrucco Puig

Lima, Peru

Location

Hospital Dos de Mayo

Lima, Peru

Location

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Frederick Altice, M.D., M.A

    Yale University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

David Oliveros, MPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: PWH in Peru and HIV clinicians prescribing ART.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2025

First Posted

July 8, 2025

Study Start (Estimated)

July 1, 2027

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

July 1, 2028

Last Updated

July 8, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations